1. Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis

   • Junyong Ou
   • Kailan Zhen
   • Cheng Liu

   Research Open access 22 May 2023 Pages: 9517 - 9528

   

2. Polydatin radiosensitizes lung cancer while preventing radiation injuries by modulating tumor-infiltrating B cells

   • Jiaming Guo
   • Wen Ding
   • Jianming Cai

   Research Open access 23 May 2023 Pages: 9529 - 9542

   

3. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases

   • Chao Sun
   • Xuehuan Liu
   • Yiming Li

   Research 23 May 2023 Pages: 9543 - 9555

   

4. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles

   • Tahereh Alinejad
   • Shabnam Modarressi
   • Cheng Shui Chen

   Review Open access 24 May 2023 Pages: 9557 - 9575

   

5. Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma

   • Wei Wang
   • Chen Wu
   • Shifeng Xu

   Research Open access 24 May 2023 Pages: 9577 - 9586

   

6. Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma

   • Wenhao Chen
   • Xinyu He
   • Guannan Bai

   Research Open access 24 May 2023 Pages: 9587 - 9595

   

7. The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients

   • Yimin Shen
   • Yuanyuan Li
   • Xiao Chen

   Research 24 May 2023 Pages: 9597 - 9608

   

8. Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics

   • Naihong Wang

   Research 24 May 2023 Pages: 9609 - 9619

   

9. Potential drug–drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey

   • Aslınur Albayrak
   • Tuğdenur Düzenli
   • Erkan Kayıkçıoğlu

   Research 24 May 2023 Pages: 9621 - 9627

10. The application value of the clinical nursing pathway for patients with head and neck cancer

    • Lingxue Yin

    Research 25 May 2023 Pages: 9629 - 9634

11. Identification of a distinct tumor endothelial cell-related gene expression signature associated with patient prognosis and immunotherapy response in multiple cancers

    • Xianhua Zhuo
    • Cheng Huang
    • Ping-Pui Wong

    Research 25 May 2023 Pages: 9635 - 9655

    

12. Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study

    • Zhenkai Luo
    • Binbin Jiao
    • Zhaoqiang Jiang

    Research 25 May 2023 Pages: 9657 - 9670

    

13. The distribution pattern of pelvic lymph nodal metastases in cervical cancer

    • Shangdan Xie
    • Jing Zhao
    • Chao Wang

    Research Open access 26 May 2023 Pages: 9671 - 9677

    

14. The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer

    • Nikola Zmarzły
    • Szymon Januszyk
    • Beniamin Oskar Grabarek

    Research Open access 26 May 2023 Pages: 9679 - 9689

    

15. Uptake of H-ferritin by Glioblastoma stem cells and its impact on their invasion capacity

    • Bhavyata (Pandya) Shesh
    • Becky Slagle-Webb
    • James R. Connor

    Research 26 May 2023 Pages: 9691 - 9703

    

16. AHR, a novel inhibitory immune checkpoint receptor, is a potential therapeutic target for chemoresistant glioblastoma

    • Nian Tan
    • Wei Zhao
    • Yuhong Bian

    Research 26 May 2023 Pages: 9705 - 9720

    

17. Involvement of spleen is associated with shorter survival in patients with angioimmunoblastic T cell lymphoma

    • Yingdan Huang
    • Ruolan Zeng
    • Huijing Wu

    Research 27 May 2023 Pages: 9721 - 9726

    

18. Efficacy of adjuvant radiation in early-stage cancers of buccal mucosa: an institutional experience

    • Surekha Goyal
    • Vedamanasa Ikkurthi
    • S. N. Geeta

    Research 27 May 2023 Pages: 9727 - 9732

    

19. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and immunotherapy response in bladder cancer

    • Xuezhong Shi
    • Ani Dong
    • Xiaocan Jia

    Research 27 May 2023 Pages: 9733 - 9746

    

20. Clinicopathologic and prognostic factors of patients with T3/T4 colorectal signet ring cell carcinoma: a population-based study

    • Fan Zhang
    • Boqi Xu
    • Zhongqi Mao

    Research Open access 28 May 2023 Pages: 9747 - 9756

    

21. A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy

    • Ping Wang
    • Kaige Chen
    • Wei Meng

    Research Open access 29 May 2023 Pages: 9757 - 9765

    

22. Intraoperative frozen section in gynaecology cancers with special reference to ovarian tumours: time to “unfreeze” the pitfalls in the path of the Derby horse of Oncology

    • Dimpy Begum
    • Debabrata Barmon
    • Karthik Chandra Bassetty

    Research 29 May 2023 Pages: 9767 - 9775

    

23. Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer

    • Sophia Kästle
    • Matthias R. Stechele
    • Melanie A. Kimm

    Research Open access 29 May 2023 Pages: 9777 - 9786

    

24. Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1

    • Lin Yang
    • Jiahao Liu
    • Jing Xiong

    Research 29 May 2023 Pages: 9787 - 9804

    

25. Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC

    • Xing Zhang
    • Longkun Yang
    • Fulan Hu

    Research 29 May 2023 Pages: 9805 - 9821

    

26. Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment

    • Wenguang Gao
    • Kun Zhang

    Review 29 May 2023 Pages: 9823 - 9838

    

27. Model for predicting prognosis and immunotherapy based on CD⁺8 T cells infiltration in neuroblastoma

    • Wei Bao
    • Zhiping Song
    • Kai Le

    Research 29 May 2023 Pages: 9839 - 9855

    

28. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas

    • Liguo Ye
    • Shi’ao Tong
    • Wenbin Ma

    Research 29 May 2023 Pages: 9857 - 9876

    

29. A robust gene prognostic index composed of GZMB, IRF1, and TP63 can stratify the risk of two metastatic urothelial carcinoma cohorts based on immune checkpoint blockade therapy

    • Jiaxing Lin
    • Mengting Ding
    • Tao Xu

    Research 29 May 2023 Pages: 9877 - 9890

    

30. The long-term course and relationship with survival of multidimensional fatigue in patients with brain metastases after Gamma Knife radiosurgery

    • Eline Verhaak
    • Wietske C. M. Schimmel
    • Karin Gehring

    Research Open access 30 May 2023 Pages: 9891 - 9901

    

31. Fusion protein and hemagglutinin of canine distemper virus co-induce apoptosis in canine mammary tumor cells

    • Chenchen Gu
    • Jun Su
    • Weiquan Liu

    Research 30 May 2023 Pages: 9903 - 9918

    

32. Survival benefit of radiotherapy and nomogram for patients with primary tracheal malignant tumors: a propensity score-matched SEER database analysis

    • Zhen Zheng
    • Zhennan Du
    • Kaitai Liu

    Research Open access 30 May 2023 Pages: 9919 - 9926

    

33. Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias

    • Chao-Yue Ku
    • Xue-Ke Yang
    • Zhi-Guang Ping

    Research 30 May 2023 Pages: 9927 - 9935

    

34. Growth assessment of pure ground-glass nodules on CT: comparison of density and size measurement methods

    • Yifan He
    • Ziqi Xiong
    • Zhiyong Li

    Research 30 May 2023 Pages: 9937 - 9946

    

35. Short- and long-term outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy in non-small cell lung cancer patients aged 35 years or younger: a real-world study with propensity score-matched analysis

    • Hanbo Pan
    • Jiaqi Zhang
    • Qingquan Luo

    Research Open access 30 May 2023 Pages: 9947 - 9958

    

36. Flexible nursing in patients with lung cancer who received chemotherapy

    • E. Jin

    Research 31 May 2023 Pages: 9959 - 9963

37. Lifestyle, clinical and histological indices-based prediction models for survival in cancer patients: a city-wide prospective cohort study in China

    • Ce Sun
    • Huan Xu
    • Lin Xu

    Research 31 May 2023 Pages: 9965 - 9978

    

38. Postmastectomy radiotherapy in patients with T_1-2N₁ breast cancer: a single center experience and a meta-analysis

    • Meng Luo
    • Yao Jin
    • Jiaojiao Zhou

    Research 31 May 2023 Pages: 9979 - 9990

    

39. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging

    • Kun-Peng Feng
    • Kai Fu
    • Chang Li

    Research 31 May 2023 Pages: 9991 - 9998

    

40. Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes

    • Die Mu
    • Hui Tang
    • Cuimin Zhu

    Research Open access 31 May 2023 Pages: 9999 - 10013

    

41. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia

    • Cong Deng
    • Tiansheng Zeng
    • Lin Fu

    Research 01 June 2023 Pages: 10015 - 10025

    

42. To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations

    • Ruoxue Cai
    • Hongyu Zhu
    • Ying Fang

    Review Open access 01 June 2023 Pages: 10027 - 10040

43. TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis

    • Bin Jiang
    • Liwen Hu
    • Weidong Hu

    Research 01 June 2023 Pages: 10041 - 10052

    

44. Low-dose total body irradiation enhances systemic anti-tumor immunity induced by local cryotherapy

    • Yin Liao
    • Yao Chen
    • Jingbo Wu

    Research 01 June 2023 Pages: 10053 - 10063

    

45. Clinicopathological characteristics and prognosis of Merkel cell carcinoma: a single-center retrospective study in Korea

    • Ik Jun Moon
    • Hyungmin Na
    • Woo Jin Lee

    Research 01 June 2023 Pages: 10065 - 10074

    

46. Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU)

    • Matthias Mäurer
    • Jonas Staudacher
    • on behalf of the Young Oncologists United (YOU)

    Research Open access 01 June 2023 Pages: 10075 - 10084

    

47. Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors

    • Francesca Monittola
    • Marzia Bianchi
    • Rita Crinelli

    Research Open access 01 June 2023 Pages: 10085 - 10097

    

48. Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma

    • Renyi Yang
    • Xiaopeng Yu
    • Puhua Zeng

    Research 02 June 2023 Pages: 10099 - 10108

    

49. Correlation between androgen receptor expression and pathological response rate in pre-operative HER2-positive breast cancer patients

    • Na Li
    • Jingxuan Wu
    • Wenlin Chen

    Research 02 June 2023 Pages: 10109 - 10117

    

50. Evaluation of a population-based breast cancer screening in North China

    • Siqi Wu
    • Di Liang
    • Yutong He

    Research Open access 02 June 2023 Pages: 10119 - 10130